SARS-CoV-2: genome sequence prevalence and growth rate
These documents provide regular updates on SARS-CoV-2 lineage prevalence and growth rates.
Applies to England
Documents
Details
Routine updates on SARS-CoV-2 lineage prevalence and growth rates.
See also technical briefing documents and underlying data on novel SARS-CoV-2 variants.
Data applies to England unless otherwise stated.
Last updated
-
Added 21 February 2024 update.
-
Added 31 January 2024 update.
-
Added 6 December update.
-
Updated list of lineages estimated to have a positive growth rate advantage with reasonable uncertainty in Variant modelling section of 8 November update.
-
Added 8 November update.
-
Added 25 October update.
-
Added 11 October update.
-
Added 27 September update.
-
Added 30 August report.
-
Added 16 August report.
-
Added 2 August report.
-
Added 19 July report.
-
Corrected dates for the sampling range for GLM and GAM in the 5 July report, Variant modelling section.
-
Added 5 July report.
-
Added 21 June report.
-
Added 7 June report.
-
First published.
Update history
2024-05-03 10:15
Added 1 May 2024 update.
2024-03-27 15:33
Added 27 March 2024 update.
2024-02-21 15:58
Added 21 February 2024 update.
2024-01-31 14:00
Added 31 January 2024 update.
2023-12-06 14:00
Added 6 December update.
2023-11-08 16:28
Updated list of lineages estimated to have a positive growth rate advantage with reasonable uncertainty in Variant modelling section of 8 November update.
2023-11-08 15:17
Added 8 November update.
2023-10-25 14:00
Added 25 October update.
2023-10-11 14:00
Added 11 October update.
2023-08-30 16:04
Added 30 August report.
2023-08-16 15:44
Added 16 August report.
2023-08-02 12:22
Added 2 August report.
2023-07-19 09:30
Added 19 July report.
2023-07-05 14:25
Corrected dates for the sampling range for GLM and GAM in the 5 July report, Variant modelling section.
2023-07-05 12:17
Added 5 July report.
2023-06-21 13:13
Added 21 June report.
2023-06-07 09:30
Added 7 June report.
2023-05-24 09:30
First published.